Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination › Research Explorer

DOI

https://doi.org/10.1016/j.ebiom.2021.103589
Final published version

Amsterdam UMC COVID-19 S3/HCW study group

Original language	English
Article number	103589
Journal	EBioMedicine
Volume	72
DOIs	https://doi.org/10.1016/j.ebiom.2021.103589
Publication status	Published - 1 Oct 2021

Research areas

BNT162b2, COVID-19, Humoral immune response, Neutralisation, SARS-CoV-2, Vaccine

ID: 19886227